Intolerance to iodine-containing contrast media;Intolerance aus produits de contraste iodes

Feuillets de Radiologie

Volumn 37, Issue 1, 1997, Pages 44-55

  Madani, A ^a   Michils, A ^a   Duchateau, J ^a   Struyven, J ^a   Gevenois, P A ^a  

^a NONE

Author keywords

adverse reactions; anaphylactoid reactions; toxicity; X ray contrast media

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIATRIZOATE; HYDRALAZINE; INTERLEUKIN 2; IODAMIDE; IODINATED CONTRAST MEDIUM; IOPROMIDE; IOTALAMIC ACID; IOTROLAN; IOXAGLIC ACID; METRIZOIC ACID;

ARTICLE; CONTRAST RADIOGRAPHY; DRUG TOXICITY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY;

EID: 0031002359     PISSN: 01819801     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (133)

1. Osborne ED, Sutherland CG, Scholl AJ, Rowntree LG. Roentgenography of urinary tract during excretion of sodium iodide. JAMA 1923; 80 : 368-373.
2. Lieberman Ph. Anaphylactoid reactions to radiocontrast material. Clin Rev Allerg 1991; 9 : 319-338.
3. Morris TW. X-ray contrast media : where are we now, and where are we going ? Radiology 1993; 188 : 11-16.
4. Lawrence V, Matthal W, Hartmaier S. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Invest Radiol 1992; 27 : 2-27.
5. Gavant ML. Low-osmolar contrast media in the 1990s. Guidelines for urography in cost-sensitive environment. Invest Radiol 1993; 28 : 13-19.
6. Siegle RL. Rates of idiosyncrastic reactions. Ionic versus nonionic contrast media. Invest Radiol 1993; 28 (suppl. 5) : 95-98.
7. Golman K, Birthe KG, Nonionic dimer X-ray contrast media. Will they be of clinical benefit ? Invest Radiol 1994; 29 (suppl. 2) : 230-231.
8. Ansell G. Adverse reactions to contrast agents. Scope of problem. Invest Radiol 1970; 6 : 374-391.
9. Shehadi WH. Comments on the incidence and reporting of adverse reactions to contrast media. Radiology 1974; 113 : 219-222.
10. Powe NR, Moore RD, Steinberg EP. Adverse reactions to contrast media : factors that determine the cost of treatment. AJR 1993; 161 : 1089-1095.
11. Shehadi WH, Tonolio G. Adverse reactions to contrast media. Radiology 1980; 137 : 299-302.
12. Shehadi WH. Contrast media adverses reactions : occurrence, recurrence and distribution patterns. Radiology 1982; 143 : 11-17.
13. Mishkin MM. Contrast media safety : what do we know and how do we know it ? Am J Cardiol 1990; 66 : 34-36.
14. Palmer FJ. The RACR survey of intravenous contrast media reactions : final report. Australas Radiol (abstract) 1988; 32 : 426-428.
15. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and non ionic contrast media. Radiology 1990; 175 : 621-628.
16. Kanzaki T, Sakagami H. Late phase allergic reaction to a CT contrast medium (Iotrolan). J Dermatol 1991; 18 : 528-531.
17. Eliashiv S, Wirguin I, Brenner T, Argov Z. Aggravation of human and experimental myasthenia gravis by contrast media. Neurology 1990; 40 : 1625-1628.
18. Ansell G. Epidemiology of adverse reactions to intravascular iodinated contrast media. Toxicol Lett 1992; 65 : 717-723
19. Almén T. The etiology of contrast medium reactions. Invest Radiol 1994; 29 (suppl. I) : 37-45.
20. Dawson P. Chemotoxicity of contrast media and clinical adverse effects : a review. Invest Radiol 1985; 20 : 84-91.
21. Lasser EC, Lang JH. Acetylcholinesterase inhibition by some organic contrast agents. Invest Radiol 1966; 2 : 237-242.
22. Dawson P, Edgerton D. Contrast media and enzyme inhibition. I. Cholinesterase. Br J Radiol 1983; 56 : 653-656.
23. Krause W, Niehues D, Biochemical characterization of X-ray contrast media. Invest Radiol 1996; 31 : 30-42.
24. Harnisch PP, Fountaine H, Ebrahimi R. Iodixanol. Experience in 1,259 patients in the United States. Invest Radiol 1994; 29 : 236-237.
25. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Matsuura K, Nakata H, Tanabe M, Brunger C, JCSCM. Full-scale investigation into adverse reaction in Japan. Invest Radiol 1991; 26 : 33-36.
26. Gertsman BB. Epidemiologic critique of the report on adverse reactions to ionic and non ionic media by the Japanese Committee on the safety of contrast media Radiology 1991; 178 : 787-790.
27. McClennan BL. Adverse reactions to iodinated contrast media. Invest Radiol 1994; 29 (suppl. 1) : 46-50.
28. Lasser EC, Berry CC. Adverse reactions to contrast media. Ionic and non ionic media and steroids. Invest Radiol 1991; 26 : 402-403.
29. Wirell S. Release of protein bound progesterone in human serum by ioglycamide. Acta Radiol Diagn 1982; 23 : 405-407.
30. Lang DM, Alpern MB, Visintainer PF, Smith ST. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol 1995; 95 : 813-817.
31. Enright T, Chua-Lim A, Duda E, Lim DT. The role of a documented allergic profile as a risk factor for radiographic contrast media reaction. Ann Allergy 1989; 62 : 302-305.
32. Elias JA. Systemic reaction to radiocontrast media during hysterosalpingography. J Allergy Clin Immun 1980; 66 : 242-243.
33. Johenning PW. Reactions to contrast material during retrograde pyelography. Urology 1980; 25 : 442-443.
34. Shehadi WH. Adverse reactions to intravasculary administered contrast media : a comprehensive study based on prospective survey. AJR 1975; 124 : 145-152.
35. Ayabe Z, Nishitanic HO, Baba H, Kawahira H, Uchino A, Matsuura K. Reactions to contrast media according to injection time : incidence and clinical characteristics. Nippon Igaku Hashasen Gakkai Zass (abstract). 1982; 42 : 766-772.
36. Duddy MJ, Manns RA, Wormald SA. Injection rate : a factor in contrast reaction ? Clin Radiol 1990; 41 : 42-43.
37. Vergara M, Seguel S. Adverse reactions to contrast media in CT : effects of temperature and ionic property. Radiology 1996; 199 : 363-366.
38. Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma. Ann Intern Med 1991; 115 : 270-276.
39. Reynolds NJ, Wallington TB, Burton JL. Hydrallazine predisposes to acute cutaneous vasculitis following urography with iopramidol. Br J Dermalot 1993; 29 . 82-85.
40. Goodfellow T, Holdstock GE, Brunton FJ, Bamforth J. Fatal acute vasculitis after high dose urography with iohexol. Br J Radiol 1986, 59 : 620-621.
41. Stone OJ. Proliferative iododerma. A possible mechanisms. Int J Dermatol 1985; 24 : 565-566.
42. Zukiwski AA, David CL, Coan J, Wallace S, Gutterman JU, Mavligit GM. Increased incidence of hypersensitivity to iodinecontaining radiographic contrast media after IL-2 administration. Cancer 1990; 65 : 1521-1524
43. Shulman KL, Thompson JA, Benyunes MC, Winter TC, Fefer A. Adverse reactions to intravenous contrast media in patients treated with IL-2. J Immunotherapy 1993; 13 : 208-212.
44. Oldham RK, Brogely J, Braud E. Contrast medium ≪recalls≫ interleukin-2 toxicity (Letter). J Clin Oncol 1990; 8 : 942.
45. Fishman JE, Aberle DR, Moldawer NP, Belldegrun A, Figlin RA Atypical contrast reactions associated with systemic interleukin-2 therapy. AJR 1991; 156 : 833.
46. Choyke DL, Miller DL, Lotze MT, Whiteis JM, Ebbitt B, Rosenberg ST. Delayed reactions to contrast media after IL-2 immunotherapy. Radiology 1992; 183 : 111-114.
47. Lalli AF. Urographic contrast media reactions and anxiety. Radiology 1974; 112 : 267-271.
48. Lalli AF. Contrast media reactions : data analysis and hypothesis. Radiology 1980; 134 : 1-12.
49. Lalli AF, Grennstreet R. Reactions to contrast media : testing the CNS hypothesis. Radiology 1981; 138 : 47-49.
50. Lasser EC, Lang JH, Lyon SG, Hamblin E, Howard M. Glucocorticoid-induced elevations of C1-esterase inhibitor : a mechanism for protection against lethal dose range contraste challenge in rats. Invest Radiol 1981; 16 : 20-23.
51. Wilson AJ, Sage MR. Cytochemical studies on contrast-medium induced blood-brain-damage. Invest Radiol 1994; 29 : 105-107.
52. e éd., Moshy, pp. 1-17.
53. Lieberman Ph. Anaphylactoid reactions to radiocontrast material. Ann Allergy 1991; 67 : 91-100.
54. Arroyave CM, Schatz M, Simon RA. Activation of the complement system by radiographic contrast media : studies in vivo and in vitro. J Allergy Clin Immunol 1979; 63 : 276-280.
55. Neoh SH, Sage MR, Willis RB, Roberts-Thomson P, Bradley J. The in vitro activation of complement by radiologic contrast materials and its inhibition with ε-aminocaproic acid. Invest Radiol 1981; 16 : 152-158.
56. Arroyave CM, Tan EM. Mechanism of complement by radiographic contrast media. Clin Exp Immunol 1977; 29 : 87-94.
57. Hasselbacher P, Hahn J. In vitro effects of radiographic contrast media on the complement system. J Allergy Clin Immunol 1980; 66 : 217-222.
58. Durda PJ, Pagano RJ, Bauman N, Brockman JA. Effects of idiopamide on human C3 and factor B in vitro. J Allergy Clin Immunol 1982; 70 : 353-360.
59. Kolb W, Lang J, Lasser EC. Non immunologic complement activation in normal human serum induced by radiographic contrast media. J Immunol 1978; 121 : 1232-1238.
60. Till G, Rother U, Gemsa D. Activation of complement by radiographic contrast media : generation of chemotactic and anaphylatosin activities. Int Arch Allergy Appl Immunol 1978; 56 : 543-550.
61. Lasser EC, Lang JH, Lyon SG, Hamblin AE. Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material : some considerations of pathogenesis. Invest Radiol 1980; 15 : 6-12.
62. Gonsette RE, Delmotte P. In vivo activation of serum complement by contrast media : a clinical study. Invest Radiol 1980; 15 : 26-28.
63. Arroyave CM, Bhat KN. Crown R. Activation of the alternative pathway of the complement system by radiographic contrast media. J Immunol 1976; 117 : 1866-1869.
64. Lasser EC, Lang JH, Lyon SG, Hamblin AE. Complement and contrast material reactions. J Allergy Clin Immunol 1979; 64 : 105-112.
65. Lieberman Ph, Siegle RL. Complement activation following intravenous material administration. J Allergy Clin Immunol 1979, 64 : 13-17.
66. Freyira AM, Pinet A, Belleville J, Eloy R, Traeger J. Effects of five different contrast agents on serum complement and calcium levels after excretory urography. J Allergy Clin Immunol 1982; 69 : 397-403.
67. Von Zabern I, Przyklenk H, Nolle R, Vogt W. Effect of metrizamide, a non ionic radiographies contrast agent, on human serum complement. Int Archs Allergy Immun 1984; 73 : 321-329.
68. Akagi M, Masaki S, Kitazumi K, Moi M, Tasaka K. Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. II. Complement system and endothelial cells. Meth Find Clin Pharmacol 1991; 13 : 449-454.
69. Von Zabern I, Przyklenk H, Vogt W, Sachsenheimer W. Effect of radiographic contrast media on complement components C3 and C4 : generation of C3b-like C3 and C4b-like C4. Int J Immunapharmac 1983; 5 : 503-513.
70. Dawson P, Turner MW. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents. Br J Radiol 1983; 56 : 447-448.
71. Chamberlain WH, Stockman GD, Wray NP. Shock and non-cardiogenic pulmonary oedema following meglumine diatrizoate for intravenous pyelography. Am J Med 1979; 67 : 684-686.
72. Greganti MA, Flowers WM. Acute pulmonary oedema after the intravenous administration of contrast media. Radiology 1979; 132: 583-585.
73. Lasser EC, Lang JH, Hamblin AE, Lyon SG, Howard M. Activation systems in contrast idiosyncrasy. Invest Radiol 1980; 15 : 2-5.
74. Siegle RL, Lieberman Ph, Jennings BR, Rice MC. Iodinated contrast material : studies relating to complement activation, atopy, cellular association and antigenicity. Invest Radiol 1980; 15 : 13-17.
75. Siegle RL, Lieberman P. Measurement of histamine, complement components and immune complexes during patient reactions to iodinated contrast material. Invest Radiol 1976; 11 : 98-101.
76. Cogen FC, Norman ME, Dunsky E, Hirshfield J, Zweiman B. Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol 1979; 64 : 299-303.
77. Rockoff SD, Brasch R, Kuhn C, Chraplyvy M. Contrast media as histamine liberators. I. Mast cell histamine release in vitro by sodium salts of contrast media. Invest Radiol 1970; 5 : 503-509.
78. Rockoff SD, Kuhn C, Chraplyvy M. Contrast media as histamine liberators. IV. In vitro mast cell histamine release by methylglucamine salts. Invest Radiol 1970; 6 : 186-190.
79. Rockoff SD, Kuhn C, Chraplyvy M. Contrast media as histamine liberators. V. Comparison of in vitro mast cell histamine release by sodium and methylglucamine salts. Invest Radiol 1972; 7 : 177-181.
80. Lasser EC, Walters AJ, Lang JH. An experimental basis for histamine release in contrast material reactions. Radiology 1974; 110 : 49-59.
81. Brasch RC, Rockoff SD, Kunh C, Chraplyvy M. Contrast media as histamine liberators. II. Histamine release into venous plasma during intravenous urography in man. Invest Radiol 1970; 5 : 510-513.
82. Rockoff SD, Brasch R. Contrast media as histamine liberators. III. Histamine release and some associated hemodynamics effects during pulmonary angiography in the dog. Invest Radiol 1971; 6 : 110-114.
83. Siedel G, Groppe G, Meyer-Burgdorff C. Contrast media as histamine liberators in man. Agents Actions 1974; 4 . 143-150.
84. Ring J, Simon RA, Arroyave CM. Increase in vitro histamine release by radiographic contrast media in patients with a history of incompatibility. Clin Exp Immunol 1978; 34 : 302-309.
85. Rice M, Lieberman P, Siegle R, Mason J. In vitro studies of reactions to radiocontrast agents (ICM) J Allergy Clin Immunol 1981; 78 : 71.
86. Younger RE, Herrod HG, Lieberman PL, Trouy RL, Crawford LV. Characteristics of diatrizoate-induced basophil histamine release. J Allergy Clin Immunol 1986; 77 : 94-100.
87. Ring J, Arroyave CM, Frizler, Tan EM. In vitro histamine and serotonin release by radiographic contrast media. Clin Exp Immunol 1978; 32 : 105-118.
88. Ennis M, Amon EU, Lorenz W. Histamine release from canine lung and liver mast cells induced by radiographic contrast media. Agents Actions 1989; 27 : 101-103.
89. Amon EU, Ennis M, Schnabel M, Schneider C, Lorenz W. Radiographic contrast media-induced histamine release : a comparative study with mast cells from different species. Agents Actions 1989; 27 : 104-110.
90. Assem ES, Bray K, Dawson P. The release of histamine from human basophils by radiological contrast agents. Br J Radiol 1983; 57 : 647-662.
91. Kaliner M, Dyer J, Merlin S, Shelton A, Greenhill A, Treadwell G, McKenna W, Lieberman P. Increased urine histamine and contrast media reactions. Invest Radiol 1984; 19 : 116-118.
92. Pinet A, Corot C, Biot N, Eloy R. Evaluation of histamine release following intravenous injection of ionic and non ionic contrast media. Invest Radiol 1988; 23 (suppl. 1) : 174-177.
93. Akagi M, Tasaka K. Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. I. Histamine release. Meth Find Clin Pharmacol 1991; 13 : 377-384.
94. Brash RC, Caldwell JL, Fuderberg HH. Antibodies to radiographics contrast agents. Induction and characterization of rabbit antibody. Invest Radiol 1976; 11 : 1-9.
95. Walker AC, Carr DH. Reaction to radiographic contrast media : an attempt to detect specific anti-contrast medium antibodies in the sera of reactions patients. Br J Radiol 1986, 59 : 531-536.
96. Carr DH, Walker AC. Contrast media reaction : experimental evidence against the allergy theory. Br J Radiol 1984; 57 : 469-473.
97. Eggleston PA, Kagey-Sobotka A, Schlhmer RP, Lischteinstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and most cells. Am Rev Respir Dis 1987; 130 : 86-91.
98. Kanny G, Maria Y, Mentre B, Moneret-Vauthn DA. Recurrent anaphylactic shock to radiographic contrast media. Evidence supporting and exceptional IgE-mediated reaction. Allerg Immunol 1993; 25 : 425-430.
99. Brasch RC, Caldwell JL. The allergic theory of radiocontrast agent toxicity : demonstration of antibody activity in sera of patients suffering major radiocontrast reactions. Invest Radiol 1976; 11 : 347-356.
100. Brasch RC, Evidence supporting an antibody mediation of contrast media reaction. Invest Radiol 1980; 15 : 529-531
101. Lasser EC, Lang JH, Lyon SG, Hamblin E, Howard MM. Prekallikrein-kallikrein conversion rate as a predictor of contrast material catastrophies. Radiology 1981; 140 : 11-15.
102. Aronen HJ, Kivisaari L, Torstila I. Paavonen T, Meri S, Karonen SL, Standertskjöld-Nordenstam. Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media. Acta Radiologica 1992; 33 : 374-378.
103. Lasser EC Sex, surfaces, sulfation and sensitivity. Invest Radial 1991; 26 (suppl. 1): 16-19.
104. Lasser EC, Lyon SG, Petro Z. Surfaces and sensitivity in contrast material reaction. Invest Radiol 1991; 26 . 20-22.
105. Constantini R, Spottll F, Holzknecht F, Braunsteiner H. On the role of the stable plasminogen activator of the venous wall in occlusion induced fibrinolytic state. Throm Diath Haemorr 1969; 22 : 544-551.
106. Wiggins RC, Loskutoff DJ, Cockrane CG, Griffin JH, Edgington TS. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J Clin Invest 1980; 65 . 197-206.
107. Osterud B. The role of endothelial cells and subendothelial in the initiation of blood coagulation. Haemostasis 1979; 8 : 324-331.
108. Gluck JC, Gluck PA. The effects of pregnancy or asthma : a prospective study. Ann Allergy 1976; 52 : 164-168.
109. Munakata H, Isemura M, Yosizawa Z. Effects of female hormones on the activity of 3′-phospho-adenylsulfate : desulphated heparan sulfate sulphotransferase in the endometrium of rabbit uterus. Int J Biochem 1985; 17 : 1077-1083.
110. Gasperatti CM, Feldman MD, Burwell CR, Angello DA, Haugh KH, Owen RM, Powers ER. Influence of contrast media or thrombus formation during coronary angioplasty. J Am Coll Cardiol 1991; 18 : 443-450.
111. Dawson P. The clotting issue: etiologic factors in thromboembolism I. Chemistry, pharmacology and toxicity of angiographic contrast agent. Invest Radial 1993; 28 : 25-30.
112. Dawson P, Cousins C, Bradshaw A. The clotting issue : etiologic factors in thromboembolism. II. Clinical considerations. Invest Radiol 1993; 28 (suppl. 5) ; 31-36.
113. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993; 88 : 2035-2044.
114. Grabowski EF, Head C, Michail HA, Jang IK, Gold H, Benoit SE, Michelson AD. Effects of contrast media on platelet activation using flowing whole blood aggregometry and flow cytometry of platelet-membrane glycoproteins. Invest Radiol 1994, 29 (suppl. 2) : 198-200.
115. Grabowski EF, Head C, Michelson AD. Non ionic contrast media. Procoagulants or clotting innocents ? Invest Radiol 1993; 28 (suppl. 5) : 21-24.
116. Stormorken H. Present state of contrast media as related to thromboembolic complications Sem Hematol 1991; 28 (suppl. 7) : 69-72.
117. Davidson CJ, Mark DB, Pieper KJ, Kisslo KB, Hlatky MA, Gabhel DA, Bashore TM. Thrombotic and cardiovascular complications related to non ionic contrast media during cardiac catheterization : analysis of 8,517 patients. Am J Cardiol 1990; 65 : 1481-1484.
118. Levorstad K, Vatne K, Brodahl U, Simonsen S, Aakhus T. Safety of the non ionic contrast medium omnipaque in coronary angiography. Cardiovascular Intervent Radiol 1989; 2 : 98-100.
119. Wisneski JA, Gertz EW, Dahlgrer M. Comparison of low osmolality ionic (ioxaglate) versus non ionic (iopamidol) contrast media in cardiac angiography. Am J Cardiol 1989; 65 : 489-495.
120. Gospos C, Freudenberg N, Staubesand J, Mathias K, Papacharlampos X. The effect of contrast media on the aortic endothelium of rats. Radiology 1983; 147 : 685-688.
121. Laerum F. Acute damage to human endothelial cells by brief exposure to contrast media in vitro. Radiology 1983; 147 : 681-684.
122. Marshall GD, Lieberman PL. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media. Ann Allergy 1991; 67 : 70-74.
123. Lieberman P. The use of antihistamines in the treatment of anaphylaxis and anaphylactoid reactions. J Allergy Clin Immunol 1990; 86 : 684-686.
124. Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991; 87 : 867-872.
125. Bush WH. Contrast media reactions : recognition and response. RSNA Categor Course Genitourinary Radiol 1994; 29-37.
126. Dawson P, Sidhu PS. Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrasts agents ? Clin Radiol 1993; 48 : 225-226.
127. Wittbrodt ET, Spinier SA. Prevention of anaphylactoid reactions in high-risk patients receiving radiographic contrast media. Ann Pharmacother 1994; 28 : 236-241.
128. Wolf GL, Mishkin MM, Roux SG, Halpern EF, Gottlieb J, Zimmerman J, Gillen J, Thellman C. Comparison of the rates of adverse drug reactions. Ionic agents, ionic agents combined with steroids and non ionic agents. Invest Radiol 1991; 26 : 404-410.
129. Greenberger PA, Patterson R, Tapio CM. Prophylaxis against repeated radiocontrast media reactions in 857 cases. Adverse experience with cimetidine and safety of β-adrenergic antagonists. Arch Intern Med 1985; 145 : 2197-2200.
130. Kelly JF, Patterson R, Lieberman P, Mathison DA, Sevenson DD. Radiographic contrast media studies in high-risk patients. J Allergy Clin Immunol 1978; 62 : 181-184.
131. Luna-Fineman S, Healy MV, Parker BR. Corticosteroid pretreatment for potential contrast reactions in children with lymphoreticular cancer : a word of caution. AJR 1990; 155 : 357-358.
132. Ring J, Rothenberger KH, Clauss W. Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined H1 et H2 receptor antagonists : résults of a prospective controlled trial. Int Arch Allergy Appl Immun 1985; 78 : 9-14.
133. Greenberger PA, Halwig JM, Patterson R, Wallemark CB. Emergency administration of a radiocontrast media in high risk patients. J Allergy Clin Immunol 1986; 77 : 630-634